| Dr Gregory Lee Fautheree, MD | |
|
10101 Park Rowe Ave Ste 200, Baton Rouge, LA 70810 | |
| (225) 769-2200 | |
| (225) 768-2185 |
| Full Name | Dr Gregory Lee Fautheree |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 21 Years |
| Location | 10101 Park Rowe Ave Ste 200, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942385703 | NPI | - | NPPES |
| 2112562 | Medicaid | LA | |
| 001635000 | Medicaid | FL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Baton rouge, LA | Home health agency |
| Our Lady Of The Lake Regional Medical Center | Baton rouge, LA | Hospital |
| The Spine Hospital Of Louisiana | Baton rouge, LA | Hospital |
| West Feliciana Parish Hospital | Saint francisville, LA | Hospital |
| St Francis Medical Center | Monroe, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Neuromedical Center | 6103716477 | 86 |
News Archive
Adults aged over 70 years who are classified as overweight are less likely to die over a ten year period than adults who are in the 'normal' weight range, according to a new study published today in the Journal of The American Geriatrics Society.
According to a recent study, there is a new mechanism of drug release using 3D superhydrophobic materials that utilizes air as a removable barrier to control the rate at which drug is released.
Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer, according to a study* released today by scientists from the National Cancer Institute (NCI).
Researchers have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis, pointing to a potential new treatment using drugs previously developed for atherosclerosis.
› Verified 2 days ago
| Entity Name | Neuromedical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740216399 PECOS PAC ID: 6103716477 Enrollment ID: O20040318001606 |
News Archive
Adults aged over 70 years who are classified as overweight are less likely to die over a ten year period than adults who are in the 'normal' weight range, according to a new study published today in the Journal of The American Geriatrics Society.
According to a recent study, there is a new mechanism of drug release using 3D superhydrophobic materials that utilizes air as a removable barrier to control the rate at which drug is released.
Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer, according to a study* released today by scientists from the National Cancer Institute (NCI).
Researchers have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis, pointing to a potential new treatment using drugs previously developed for atherosclerosis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Lee Fautheree, MD Po Box 98509, Baton Rouge, LA 70884-9509 Ph: (225) 769-2200 | Dr Gregory Lee Fautheree, MD 10101 Park Rowe Ave Ste 200, Baton Rouge, LA 70810 Ph: (225) 769-2200 |
News Archive
Adults aged over 70 years who are classified as overweight are less likely to die over a ten year period than adults who are in the 'normal' weight range, according to a new study published today in the Journal of The American Geriatrics Society.
According to a recent study, there is a new mechanism of drug release using 3D superhydrophobic materials that utilizes air as a removable barrier to control the rate at which drug is released.
Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer, according to a study* released today by scientists from the National Cancer Institute (NCI).
Researchers have shown how controlling cholesterol metabolism in pancreatic cancer cells reduces metastasis, pointing to a potential new treatment using drugs previously developed for atherosclerosis.
› Verified 2 days ago
Scott W. Soleau, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 10101 Park Rowe Ave, Suite 200, Baton Rouge, LA 70810 Phone: 225-769-2200 Fax: 225-768-2185 | |
Thomas B Flynn, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 10101 Park Rowe Ave, Suite 200, Baton Rouge, LA 70810 Phone: 225-769-2200 Fax: 225-768-2185 | |
Brandon Gerard Gaynor, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 10101 Park Rowe Ave Ste 200, Baton Rouge, LA 70810 Phone: 225-769-2200 Fax: 225-768-2185 | |
John R Clifford, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 10101 Park Rowe Ave, Suite 200, Baton Rouge, LA 70810 Phone: 225-769-2200 Fax: 225-768-2185 | |
Dr. Marvin Dementreous Clifton, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 4884 Constitution Ave, Ste 1e, Baton Rouge, LA 70808 Phone: 225-923-1621 Fax: 225-923-1623 | |
Dr. Anthony S Ioppolo, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 7777 Hennessy Blvd Plaza 1, 709, Baton Rouge, LA 70808 Phone: 225-757-1960 Fax: 225-757-1959 | |
Dr. Garrett Venable, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 10101 Park Rowe Ave, Baton Rouge, LA 70810 Phone: 225-768-2164 |